- Home
- GNL vs PRGO Comparison
GNL vs PRGO Comparison
Compare GNL & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNL | PRGO |
|---|---|---|
| Founded | 2011 | 1887 |
| Country | United States | Ireland |
| Employees | 56 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | GNL | PRGO |
|---|---|---|
| Price | $9.42 | N/A |
| Analyst Decision | Buy | |
| Analyst Count | 2 | |
| Target Price | $9.50 | N/A |
| AVG Volume (30 Days) | 1.9M | N/A |
| Earning Date | 05-06-2026 | 04-05-2026 |
| Dividend Yield | 8.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.51 | N/A |
| 52 Week High | $10.04 | N/A |
Technical Indicators
Market Signals| Indicator | GNL | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 50.10 |
| Support Level | $9.17 | $9.23 |
| Resistance Level | $9.75 | $15.08 |
| Average True Range (ATR) | 0.19 | 0.53 |
| MACD | 0.01 | 0.30 |
| Stochastic Oscillator | 44.87 | 77.29 |
Price Performance
Historical ComparisonAbout GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.